Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-580-7 | CAS number: 64-19-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP, non- guideline study, published in peer reviewed literature. No restrictions, fully adequate for assessment.
Data source
Reference
- Reference Type:
- publication
- Title:
- Antihypertensive effects of acetic acid and vinegar on spontaneously hypertensive rats
- Author:
- Kondo S, Tayama K, Tsukamoto Y, Ikeda K and Yamori Y
- Year:
- 2 001
- Bibliographic source:
- Biosci. Biotechnol. Biochem Vol 65, (12), pp 2690-2694
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Deviations:
- not applicable
- Principles of method if other than guideline:
- Groups of 6 spontaneously hypertensive rats were fed diets containing 6% (w/w) acetic acid , 6% (w/w) rice vinegar or control diet for 8 weeks. Blood pressure, heart rate, body weight, food intake and water consumption were measured at weekly intervals. Urine samples were collected every 2 weeks for measurements of volume, sodium, calcium and catecholamine excretion. After 8 weeks, animals were killed and blood samples collected from the aorta. The heart, aorta, kidneys and lungs were removed and the angiotensin I-converting enzyme (ACE) activity was measured.
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Acetic acid
- EC Number:
- 200-580-7
- EC Name:
- Acetic acid
- Cas Number:
- 64-19-7
- Molecular formula:
- C2H4O2
- IUPAC Name:
- acetic acid
- Details on test material:
- - Name of test material (as cited in study report): acetic acid
- Physical state: liquid
- Composition of test material, percentage of components: 46.2 g/L acetic acid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: spontaneously hypertensive rats
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hoshino Laboratory Animals, Japan
- Age at study initiation: 4 weeks old
- Weight at study initiation: not reported
- Fasting period before study: none
- Housing: Metabolic cages (no further details reported)
- Diet: Labo MR stock diet, Nihon Nosan Kogyo KK, was mixed 6% with deionised water (control), acetic acid or rice vinegar and fed ad libitum
- Water: tap water ad libitum.
- Acclimation period: 6 days (fed on control diet)
ENVIRONMENTAL CONDITIONS
- Temperature: 24 ± 2°C
- Humidity: 50 ± 10%
- Air changes (per hr): no data
- Photoperiod: 12 hrs dark / 12 hrs light (light from 07:00 to 19:00)
IN-LIFE DATES: not reported
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- DIET PREPARATION
- Rate of preparation of diet (frequency): not reported
- Mixing appropriate amounts with (Type of food): standard laboratory diet mixed 6% (w/w) with deionised water, acetic acid or rice vinegar
- Storage temperature of food: not reported - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 8 weeks
- Frequency of treatment:
- daily
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
6% (w/w)
Basis:
nominal in diet
- Remarks:
- Doses / Concentrations:
290 mg/kg bw/d
Basis:
actual ingested
- No. of animals per sex per dose:
- 6
- Control animals:
- yes, sham-exposed
- Details on study design:
- - Dose selection rationale: Vinegar extracts are thought to play a role in blood pressure reduction but the main components of commercial vinegar are acetic acid and saccharides. This study aimed to clarify the possibility of the preventative effects of long-term administration of dietary vinegar and pure acetic acid on hypertension using spontaneously hypertensive rats (SHR), a model for human hypertension.
- Rationale for animal assignment (if not random): After acclimatisation to the control diet, 18 animals were divided into 3 groups of 6 animals, so that each group had the same mean bodyweight and blood pressure.
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: No data
- Time schedule: Not specified
DETAILED CLINICAL OBSERVATIONS: No data
BODY WEIGHT: Yes
- Time schedule for examinations: Weekly
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/day/rat: Yes
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No data
WATER CONSUMPTION: Yes
- Time schedule for examinations: Weekly
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: No
CLINICAL CHEMISTRY: No
URINALYSIS: Yes
- Time schedule for collection of urine: every other week
- Metabolism cages used for collection of urine: Yes
- Animals fasted: No data
- Urine volume, sodium, calcium and catecholamine excretion were examined
NEUROBEHAVIOURAL EXAMINATION: No
OTHER: At termination, blood was taken from the aorta ventralis, EDTA plasma was prepared and analysed, using radioimmunoassays, to detect renin activity, angiotensin II, aldosterone and PGE2 - Sacrifice and pathology:
- All rats were killed under pentobarbitone anaesthesia (30 mg/kg). The heart, aorta, kidneys and lungs were removed.
GROSS PATHOLOGY: No
HISTOPATHOLOGY: No - Other examinations:
- Angiotensin I converting enzyme (ACE) activity was measured from the heart, aorta, kidneys and lungs. Enzyme extracts were prepared by chopping each organ into small pieces and homogenising in 50mm Tris HCl (pH 7.9) containing 0.3M NaCl. The suspension was centrifuged and the resulting supernatent fluid was centrifuged again. The pellet was suspended in a 0.1M sodium borate buffer (pH8.3) containing 0.3M NaCl and the suspension was used as the enzyme extract. The ACE activity was assayed according to Kasahara and Ashihara.
- Statistics:
- All values were expressed as means ± SD. Student's t-test was used to evaluate the significance of any differences in the ACE activity of each organ. An analysis of variance (ANOVA) was used to evaluate differences between the groups; when ANOVA indicated any significant differences between the means, Fisher's PLSD test was used to find which means were significantly different. P< 0.05 was defined as significant.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- no effects observed
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- not examined
- Details on results:
-
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study)
The average food consumption of the control group was 18.8 ± 2.4 g/day/rat and those of the acetic acid and rice vinegar groups were 19.3 ± 2.6 and 19.1 ± 2.4 g/day/rat, respectively. These food intakes corresponded to the ingestion of about 0.86 mmol/day/rat of acetic acid.
BLOOD PRESSURE
The blood pressure of rats in both experimental groups tended to be lower than the controls after 8 weeks of age and significant differences were observed after 10 weeks of age in both groups. Blood pressure values for the acetic acid and rice vinegar groups were 164 ± 12.4 and 165.2 ± 18.5 mmHg at 11 weeks of age, respectively, while that for the control group was 186.2 ± 7.8 mmHg at the same age; a 21 mmHg decrease in blood pressure was observed. At 13 weeks of age, the end of the feeding period, the rice vinegar group showed a statistically significant decrease in blood pressure of -30 mmHg compared to the control group. At 13 weeks the blood pressure of the acetic acid group was 13 mmHg lower than that of the control group but this did not attain statistical significance.
ACE ACTIVITY AND PLASMA BIOCHEMISTRY
The angiotensin converting enzyme (ACE) activity of the lungs, heart, aorta and kidneys showed no significant differences from the control group. (Table 1).
Plasma renin activity and aldosterone changed significantly with the long term administration of both experimental diets (Table 2). The plasma renin activity of the acetic acid and rice vinegar groups decreased to 9.9 ± 2.2 and 8.7 ± 3.3 ng/mL/hr, respectively, compared to the control group value of 15.0 ± 2. The plasma aldosterone levels of the acetic acid and rice vinegar groups were 101 and 44.7 pg/mL, respectively, while that of the control group was 131 ± 43.5 pg/mL. However, plasma aldosterone in the rice vinegar group was statistically significantly reduced compared to both the acetic acid and control groups.
Plasma angiotensin II was slightly lower than controls in both experimental groups but this was not statistically significant.
URINE ANALYSIS
There was no significant difference in sodium excretion or catecholamine concentrations in any of the groups throughout the experimental period.
Effect levels
- Dose descriptor:
- NOAEL
- Remarks:
- bodyweight, clinical symptoms
- Effect level:
- 290 mg/kg bw/day (nominal)
- Sex:
- male
- Basis for effect level:
- other: a rise in blood pressure was observed in all groups and plasma renin activity was reduced, however these effects were considered not to be adverse in the context of establishing an NOAEL for this study
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Table 1. Angiotensin I-Converting Enzyme Activity in Organs of Spontaneously Hypertensive Rats at 13 Weeks of Age
Angiotensin I-Converting Enzyme Activity (mU/mg protein) |
||||
Group |
Lung |
Aorta |
Heart |
Kidney |
Control |
119 ± 3.3 |
3.72 ± 1.3 |
1.06 ± 0.14 |
5.19 ± 2.0 |
Acetic acid solution |
122 ± 5.2 |
3.90 ± 0.76 |
1.06 ± 0.10 |
6.65 ± 1.6 |
Feeding of the diet containing acetic acid or rice vinegar started at 5 weeks of age. Results are expressed as the mean and standard errors. There were no significant differences from the control.
Table 2. Effects of Acetic Acid and Vinegar on Blood Indices
Group |
Plasma rennin activity (ng/ml•hr) |
Plasma angiotensin II(pg/ml) |
Plasma aldosterone(pg/ml) |
Control |
15 ± 2.0 |
33.8 ± 11 |
131 ± 43.5 |
Acetic acid solution |
9.9 ± 2.2* |
25.2 ± 8.7 |
101 ± 46.9 r |
Rice vinegar |
8.7 ± 3.3** |
29.2 ± 12 |
44.7 ± 32.2* r |
Feeding of the diet containing acetic acid or rice vinegar started at 5 weeks of age. Results are expressed as the mean and standard errors. Significant difference from control: *p<0.01, **p<0.001. Symbol r indicates that there were significant differences between the acetic acid and rice vinegar groups (p <0.05).
Applicant's summary and conclusion
- Conclusions:
- No adverse effects were observed in male SHR rats with an NOAEL of 290 mg/kg bw/d
- Executive summary:
To clarify the possibility of a preventive effect of dietary vinegar on blood pressure, long-term administration of vinegar or the acetic acid to Spontaneously Hypertensive Rats was examined. As a result, it was observed that acetic acid itself, the main component of vinegar, significantly reduced both blood pressure (p<0.05) and renin activity (p<0.01), compared to controls given no acetic acid or vinegar, as well as vinegar. There were no significant differences in angiotensin I-converting enzyme activity in various organs. As for the mechanism of this function, it was suggested that this reduction in blood pressure may be caused by the significant reduction in renin activity and the subsequent decrease in angiotensin II. From this study, it was also suggested that the antihypertensive effect of vinegar is mainly due to the acetic acid in it.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.